86
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Clinical Grading in Chronic Graft-Versus-Host Disease: Is it Time for Change?

Pages 1211-1220 | Published online: 01 Jul 2009

  • Marks, D.I., Cullis, J.O., Ward, K.M., Lacey, S., Syzdlo, R and Hushes, T.P. (1993) "Allogeneic bone marrow transplantation for chrontic onycloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years". Annals of Internal Medicine 119, 207-214.
  • Bensinger, W.I., Martin, PJ., Storer, B., et al., (2001) "Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers". New England Journal of Medicine 344, 175-181.
  • Blaise, D. Kuentz, M., Fortanier, C., et al., (2000) "Randomized trial of bone marrow versus lenograstim-primed blood cell allogencic lnmsplantation in patients with early-stage leukemia: a report from the Societe Francaise de Greffe de Moelle". Journal of Clinical Oncology 18, 537 546.
  • Durrant, ST. and Morton, AJ. (1999) "A randomized trial of filgrastion (G CSF) stimulated donor marrow (BM) versus peripheral blood (PRC) for allogenete transplantation: increased extensive chronic graft versus host disease following PBPC transplantation (abstract)". Blood 94, 2706a.
  • Socie, G., Stone, J.V., Wingard, J.R., et al., (1999) "Long-term survival and late death-s after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry". New England Journal of Medicine 341. 14-21. see comments.
  • Montross, S., Brislin, T., Altwnonte, V. and Vogelsang, G. (1998) "The importance of confirming graft versus host disease (GVHD) diagnosis (abstract)". Blood 92. 1885a.
  • Akpek, G., Zahurak, M.L., Piantadosi, S., et al., (2001) "Development of a prognustic model for grading chronic graftversus-host disease". Blood 97, 1219-1226.
  • Atkinson, K (1990) "Chronic graft-versus-host disease review". Bone Marrow Transplantation 5, 69 -78.
  • Sullivan, K.M., Shulman, H., Storb, R., et al.,(1981) "Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression". Blood 57, 267-276.
  • Sullivan, K.M., Witherspoon, R.P., Storb, R., et al., (1988) "Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after atlogeneic marrow transplantation". Blood 72, 546-554.
  • Parkman, R. (1986) "Clonal analysis of murine graft-versus-host disease 1. Phenotypic and functional analysis of T lymphocyte clones". Journal of Immunology 136, 3543-3548.
  • Perreault, C., Decary, F., Brochu, D.A., et al., (1990) "Minor histocompatibility antigens". Blood 76, 1269 -1280.
  • Hess, A.D., Horowitz, I., Beschomer, W.E. and Santos, G.W. (1985) "Development of gralt-vertus-host disease-like syndrome in cyclosporine treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal ant-Ia specificity, including autoreactivity". Journal of Experimentol Medicine 161 718-730.
  • Hess, A.D., Bright, E.C.,Thoubum, C. Vogelsang, G.B., Jones, RJ. and Kennedy, M.J. (1997) "Specificity of effector T lymphocytes in autologous graft-versus-host disease: Role of the major histocompatibility complex class II invariant chain peplide". Blood 89. 2203-2209
  • Ferrara, J.L.M. and Antin, J.H. (1999) "The pathophysiology of graft-versus-host disease". In: Thomas, E.D., Blume, K.G. and Fonnun, S.J., eds, Hematopoietic Cell Transplantation. 2nd ed. (Blackwell Science. Massachusetts), pp 305-315.
  • Ferrara, J.L. and Krenger, W. (1998) "Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines". Transfusion Medicine Reviws 12, 1-17.
  • Krenger, W. and Ferrara, J.L. (1996) "Grati-versus-host disease and the Th1/Th2 paradigm". Immunology Reasearch 15. 50-73. review.
  • Atkinson, K., Horowitz, M.M., GaIe, R.P, et al., (1990) "Risk factors for chronic graft-versus-host disease after HLA-idcntical sibling bone marrow transplantation". Blood 75, 2459-2464.
  • Sullivan, K. Agura, E and Anasetti, C. (1991) "Chronic graft versus host disease in other late complications of bone marrow transplantation", Seminars in Hematology, 28, 250-259.
  • Sullivan, K.M. (1999) "Graft-versus-host disease". In: Thomas, E.D., Blume, K.G and Forman, S.J., eds. Hematopoietic Cell Transplantation. 2nd ed (Blackwell Science. Massachusetts). PP 515-536.
  • Sullivan, K.M. and Witherspoon, R.P. (1990) "Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation". Transplantation 22, 1336-1338.
  • Sullivan, K.M., Witherspoon, R., Storb, R. et al., (1988) "Alternating-day cyclosporini and prednisone for treatment of high-risk chronic grafl-versos-host disease". Blood 72, 555-561.
  • Vogelsang, G.B. (2001) "How I treat chronic graft-versus-host disease". Blood 97, 1196-1201.
  • Wingard, J., Piantadosi, S., Vogelsang, G., et al., (1989) "Predictors, of death from chronic graft versus host disease after bone marrow transplantation". Blood 74. 1428-1435.
  • Storb, Prentice, R.L., Sullivan, K.M., et al. (1983) "Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings". Annals of Internal Medicine 98. 461-466.
  • Shulman, H.M., Sullivan, K.M., Weiden, P.L., et al., (1980) "Chronic graft-versus host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients". American Journal of Medicine 69, 204-217.
  • Pavletic, S., Tarantolo, S., Lynch, J, et al., (1999) "Chronic graftversus-host disease after allogeneic blood stem cell or bone marrow transplantation: factors determining the onset and survival (abstract)", Proceedings of American Society of Clinical Oncology 18. 201a.
  • Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R.A., Lerner, K.G. and Thomas, E.D. (1974) "Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors", Transplantation 18, 295-304.
  • Atkinson, K., Horowitz, M.M., Gale, R.P., Lee, M.B., Rim, A.A. and Bortin, M.M. (1989) "Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease". Bone Marrow Transplantation 4. 247-254, for the Advisory Committee of the International Bone Marrow Transplant Registry
  • Tulschka, P.J., Beschomer, W.E., Allison, A.C., Burns, W.H. and Santos, G.W. (1983) "Cyclosporine A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants". Blood 61, 318-325.
  • Fanner, E.R. (1986) "The histopathology of graft-versus-host disease". Advances in Dermatology 1, 173-188.
  • Saurat, J.H., Gluckman, E., Bussell, A., Diderjean, I., and Puissant, A. (1975) "The lichen planus-like eruption after hone marrow transplantation". British Journal of Dermatology 93, 675-681.
  • Anasetti, C. Rybka, W., Sullivan, K.M., Banaji, M. and Slichter, S.J. (1989) "Graft-versus-host disease is associated with autoimmune-like thrombocytopenia", Blood 73. 1054-1058.
  • Morion, A.J., Anasetti, C., Cooley, T., et al., (1997) "Chronic graflversus-host disease (GVHD) following unrelated donor transplantation (abstract)". Blood 90, 590a.
  • Nevo, S., Enger, C., Swan, V. Wojno, K.J., Fuller, A.K., Altomonte, V., Braine, H.G., Noga, S.J. and Vogelsang, G.B. (1999) "Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival". Transplantation 15, 681-689.
  • Sullivan, K.M., Mai, M., Sanders, J., et al., (1992) "Increased late complications of allogeneic and autologous marrow transplantation". Bone Marrow Transplantation 10, 127-134.
  • Ochs, L., Shu, X.O., Miller, J., et al., (1995) "Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients". Blood 86. 3979-3986.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.